Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Recurrence × Monitoring, Physiologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Recurrence 1 Lung Neoplasms 1

Interventions

Surgical Procedures, Operative 7 Liver Transplantation 4 Lenalidomide 4 Liquid Biopsy 3 Blood Specimen Collection 3 pomalidomide 2 gilteritinib 2 Therapeutics 2 Proteasome Inhibitors 2 Observation 2 Neoadjuvant Therapy 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Immunotherapy, Adoptive 2 Immunoconjugates 2 High-Throughput Nucleotide Sequencing 2 DNA, Mitochondrial 2 Brentuximab Vedotin 2 Antibodies, Monoclonal 2 Antibodies, Bispecific 2 Amplified Fragment Length Polymorphism Analysis 2 trametinib 1 romidepsin 1 nedaplatin 1 lenvatinib 1 fluoroazomycin arabinoside 1 exemestane 1 elotuzumab 1 dacomitinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05080998 2025-11-10

LOBSTER

Pacific Edge Limited

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡